caris
CARIS SCIENCE,INC.
Süreç
- Başvuru 8 Haziran 2023
- Bültende yayın Resmî Marka Bülteni 432 · 13 Kasım 2023
- İtiraz penceresi (2 ay) Son gün 13 Ocak 2024 · kapandı
- Tescil Tescil no 2023 090706· Gazete 489 (31 Mayıs 2024)
- Yenileme Koruma 10 yıl: yenileme tarihi Haziran 2033 (son 6 ay içinde başvurulur).
Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.
Sınıflar ve kapsam
Mal ve hizmet listesi
Medical research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, cellular manipulation, light microscopic examination, immunohistochemistry flow cytometry, expression profiling, microarray analysis, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing temporary use of nondownloadable software for tracking laboratory information featuring customized biospecimens and coordinating and conducting follow-on studies to complement the clinical findings; medical and scientific research; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient history reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, prognosis, and predicting or monitoring therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes.
Aynı bültende benzer başvurular
Bülten 432 içindeki 776 aynı-sınıf başvuru arasında Nomist'in benzerlik algoritmasına takılan yok.